TransMedics (TMDX) Convertible Debt (2023 - 2026)

TransMedics' Convertible Debt history runs 4 years deep, the most recent figure standing at $453.5 million for Q1 2026.

• On a quarterly basis, Convertible Debt rose 0.64% year-over-year to $453.5 million in Q1 2026; TTM through Mar 2026 was $453.5 million, a 0.64% increase from a year earlier, with the FY2025 full-year figure at $452.8 million, up 0.64% from the prior year.
• Convertible Debt steadied at $453.5 million in Q1 2026 per TMDX's latest filing, from $452.8 million in the prior quarter.
• Across five years, Convertible Debt topped out at $453.5 million in Q1 2026 and bottomed at $445.8 million in Q2 2023.
• The 4-year median for Convertible Debt is $449.6 million (2024), against an average of $449.6 million.
• Across the five-year window, Convertible Debt climbed 0.62% in 2024 and grew 0.64% in 2026, its largest moves.
• Year by year, Convertible Debt stood at $447.1 million in 2023, then grew by 0.63% to $449.9 million in 2024, then gained by 0.64% to $452.8 million in 2025, then grew by 0.16% to $453.5 million in 2026.
• Per Business Quant, the three latest TMDX Convertible Debt figures stand at $453.5 million (Q1 2026), $452.8 million (Q4 2025), and $452.1 million (Q3 2025).